NCT06994338 - Tirzepatide for Alcohol Use Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 6, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Alcohol Use DisorderObesity and OverweightAlcohol

Interventions

DRUG

Tirzepatide

Tirzepatide injections (2.5mg, 5.0mg)

DRUG

Placebo injections

Trial Locations (1)

RECRUITING

Keck School of Medicine, University of Southern California, Los Angeles

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of Southern California

OTHER